RTX (RTX) Q3 25/26 earnings summary

Executive summary

• Wireless communication solutions provided for enterprise, healthcare, and ProAudio segments, with a focus on OEM partnerships and technology leadership.

• Revenue for the first nine months rose by 2% year-over-year to DKK 416 million, or 8.5% growth at constant currency, driven by Healthcare and ProAudio growth despite component shortages.

• Gross margin improved by 4.1 percentage points year-over-year to 54.8%, supported by favorable segment mix.

• EBITDA for the nine months reached DKK 30.1 million, up 35% year-over-year, driven by higher gross margin and segment growth.

• Strong order backlog and positive customer forecasts support continued growth.

Financial highlights

• 9M revenue: DKK 416 million (+2% YoY, +8.5% at constant currency); Q3 revenue: DKK 151 million.

• Gross margin: 54.8% for 9M (up from 50.7% YoY); Q3 gross margin: 53.3%.

• 9M EBITDA: DKK 30.1 million (+35% YoY); Q3 EBITDA: DKK 13.4 million.

• EBIT for 9M: DKK 8 million; Q3 EBIT: DKK 6 million.

• Investments in development more than doubled from DKK 31 million to DKK 72 million.

Outlook and guidance

• Full-year 2025/26 guidance raised: revenue expected at DKK 590–625 million, EBITDA at DKK 50–75 million, EBIT at DKK 20–45 million.

• Revenue guidance implies a strong Q4, with expectations of DKK 170–200 million in revenue.

• Targeting double-digit annual revenue growth and EBITDA margin above 15% by 2030.

• Profitability improvements expected to continue as higher-margin segments grow.

• Outlook reflects strong order book and ongoing supply constraints expected to persist into Q4.